Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 139

Sort by

Sort Order Select

Journal Articles

“Mast”ering drug discovery with iPSCs

Adrienne Dorrance

Blood (2021) 137 (15): 1993–1994.

https://doi.org/10.1182/blood.2020010456

Published: 2021

Journal Articles

Neurodevelopmental Disorders in Pediatric Sickle Cell Disease

Eboni I. Lance, MD, Alicia D. Cannon, PhD, Bruce K. Shapiro, MD, Michael V. Johnston, MD, James F. Casella, MD

Blood (2019) 134 (Supplement_1): 1016.

https://doi.org/10.1182/blood-2019-121968

Published: 2019

Journal Articles

Proteomic Discovery: Elevated Neurogranin Levels in Children with Sickle Cell Disease

Eboni I. Lance, MD, Lisa Faulcon, MD, Zongming Fu, PhD, Jun Yang, PhD, Donna Whyte, MD, John J. Strouse, MD, PhD, Emily Barron-Casella, PhD, Kimberly Jones, Jennifer Van Eck, PhD, James F. Casella, MD, Allen Everett, MD

Blood (2019) 134 (Supplement_1): 2296.

https://doi.org/10.1182/blood-2019-122015

Published: 2019

Journal Articles

BCL-2 Is Expressed in Advanced Mastocytosis and Midaustorin Induces Venetoclax Sensitivity of Mast Leukemia Cell Lines

Danielle Canioni, MD, Josquin Moraly, MD, Ludovic Lhermitte, MD PhD, Laura Polivka, MD, Mélanie Féroul, Julien Rossignol, MD PhD, Laurent Frenzel, MD PhD, Michel Arock, pharmD, PhD, Patrice Dubreuil, PhD, Leila maouche-Chretien, PhD, Olivier Hermine, MD PhD

Blood (2019) 134 (Supplement_1): 1683.

https://doi.org/10.1182/blood-2019-131256

Published: 2019

Journal Articles

Red Blood Transfusion Does Not Increase Risk for Venous or Arterial Thrombosis

Lisa Baumann Kreuziger, MD MS, Gustaf Edgren, Ronald G. Hauser, MD, Daniel Zaccaro, Joseph Kiss, MD, Ann Butler Zimrin, MD, Matt Westlake, Donald Brambilla, PhD, National Heart, Lung and Blood Institute Recipient Epidemiology and Donor Evaluation Study-III (REDS-III), Alan E. Mast, MDPhD

Blood (2018) 132 (Supplement 1): 415.

https://doi.org/10.1182/blood-2018-99-109844

Published: 2018

Journal Articles

Parenteral L-Arginine Improves Mitochondrial Function in Children with Sickle Cell Disease Admitted for Vaso-Occlusive Pain Episodes

Sruti Shiva, PhD, Lou Ann Brown, PhD, Y Wang, Carlton Dampier, MD, Amanda Watt, Vinita Tripathi, Amina Bhutta, MD, Polly Kumari, MD, Janet Figueroa, MPH, April Zmitrovich, MSW, MPH, Claudia R. Morris, MD

Blood (2018) 132 (Supplement 1): 508.

https://doi.org/10.1182/blood-2018-99-112666

Published: 2018

Journal Articles

Blood Donation and Iron Deficiency

Alan E. Mast, MD PhD

Blood (2018) 132 (Supplement 1): SCI-4.

https://doi.org/10.1182/blood-2018-99-109521

Published: 2018

Journal Articles

Inpatient Mortality and Length of Stay Among Direct-Acting Oral Anticoagulant (DOAC) and Warfarin Users Presenting with Major Hemorrhage

Walter Bialkowski, PhD MS, Sylvia Tan, MS, Alan E. Mast, MDPhD, Joseph Kiss, MD, Daryl J. Kor, MD MSc, Jerome Gottschall, MD, Yanyun Wu, MD PhD, Nareg H. Roubinian, MD, Darrell Triulzi, MD, Steven Kleinman, MD, Young Choi, MD, Donald Brambilla, PhD, Ann Butler Zimrin, MD, The NHLBI Recipient Epidemiology and Donor Evaluation Study-III

Blood (2018) 132 (Supplement 1): 2538.

https://doi.org/10.1182/blood-2018-99-112631

Published: 2018

Journal Articles

Critical Role of Jumonji Domain of JMJD1C in AML Leukemogenesis

Jesus Izaguirre-Carbonell, PhD, Christiansen Luke, Robert Burns, PhD, Jesse Schmitz, Chenxuan Li, Rebekah Mokry, Theresa Bluemn, Yongwei Zheng, Demin Wang, PhD, Nan Zhu, PhD

Blood (2018) 132 (Supplement 1): 2599.

https://doi.org/10.1182/blood-2018-99-110463

Published: 2018

Journal Articles

Mast Cells Contribute to Brain Microvascular Permeability in Sickle Cell Disease

Aditya M Mittal, Huy Tran, BSMedTech, Varun Sagi, BS, Aithanh Nguyen, Kathryn Luk, Julia Nguyen, BS, Jianxun Lei, PhD, Kalpna Gupta, PhD

Blood (2018) 132 (Supplement 1): 269.

https://doi.org/10.1182/blood-2018-99-117246

Published: 2018

Journal Articles

A New Prognostic Score for Advanced Systemic Mastocytosis Based on Clinical and Genetic Characteristics of 210 Consecutive Patients

Mohamad Jawhar, Juliana Schwaab, Nicole Naumann, Georgia Metzgeroth, MD, Hans-Peter Horny, Karl Sotlar, Manja Meggendorfer, PhD, Torsten Haferlach, MD, Nicholas C.P. Cross, Alice Fabarius, Wolf-Karsten Hofmann, Peter Valent, Andreas Reiter, MD

Blood (2018) 132 (Supplement 1): 349.

https://doi.org/10.1182/blood-2018-99-115804

Published: 2018

Journal Articles

Temporal and Spatially Regulated Oncogenic KIT Expression and Loss of Dnmt3a Cooperate to Drive MPN Development: Role of PI3Kinase in Dnmt3a Loss Induced Hyperproliferation in Myeloid Cells

Lakshmi Reddy Palam, PhD, Baskar Ramdas, PhD, Sridhar reddy Srivatsan, MS, Sarath Chandra Janga, PhD, Axel Roers, PhD, Alexander Gerbaulet, Reuben Kapur, PhD

Blood (2018) 132 (Supplement 1): 3055.

https://doi.org/10.1182/blood-2018-99-118721

Published: 2018

Journal Articles

AK002, a Novel Humanized Monoclonal Antibody to Siglec-8, Inhibits Mast Cell Activity and Depletes Eosinophils in Ex Vivo Bone Marrow Tissue from Patients with Systemic Mastocytosis

Bradford A Youngblood, PhD, Emily C Brock, John Leung, Alan T Chang, Christopher Bebbington, PhD, Nenad Tomasevic, PhD

Blood (2018) 132 (Supplement 1): 1104.

https://doi.org/10.1182/blood-2018-99-119232

Published: 2018

Journal Articles

BFPI: A Minimal Prothrombinase Inhibitor from the Saliva of Simulium Vittatum

Jeremy P. Wood, PhD, Xiao H. Song, Alan E. Mast, MDPhD

Blood (2018) 132 (Supplement 1): 1163.

https://doi.org/10.1182/blood-2018-99-118666

Published: 2018

Journal Articles

A Pilot Data Analysis of a Metabolomic Liquid Chromatography-Tandem Mass Spectrometry (LC/MS/MS) Based Study of Patients with Sickle Cell/Beta Thalassemia

Ioannis Papassotiriou, PhD, Christos Poziopoulos, MD, Georgia Avgerinou, MD, Claudia R. Morris, MD, Ersi Voskaridou, MD

Blood (2018) 132 (Supplement 1): 4912.

https://doi.org/10.1182/blood-2018-99-111445

Published: 2018

Journal Articles

Heme Regulates the Expression in Erythroblasts of Placenta Growth Factor, a Contributor to Pulmonary Hypertension in Sickle Cell Disease, through the Oxidant Response Transcription Factor NRF2

Maria G Kapetanaki, PhD, Oluwabukola Gbotosho, BSc, MSc, PhD, Deva Sharma, MD MS, Schrott Valerie, MS, Frances Weidert, MSc, Solomon Fiifi Ofori-Acquah, PhD, Grant C. Bullock, MD PhD, Gregory J. Kato, MD

Blood (2017) 130 (Supplement 1): 3496.

https://doi.org/10.1182/blood.V130.Suppl_1.3496.3496

Published: 2017

Journal Articles

Free Heme Induces a Heme Importer, Heme Catabolism and an Angiogenic Factor in Multiple Organs in Mice: Implications for Organ-Specific Response to Intravascular Hemolysis

Oluwabukola Gbotosho, BSc, MSc, PhD, Maria G Kapetanaki, PhD, Yu Lin, Frances Weidert, MSc, Solomon Fiifi Ofori-Acquah, PhD, Gregory J. Kato, MD

Blood (2017) 130 (Supplement 1): 3468.

https://doi.org/10.1182/blood.V130.Suppl_1.3468.3468

Published: 2017

Journal Articles

Prothrombinase Inhibition By Tfpiα Requires Three Distinct Interactions with Factors Va and X

Jeremy P. Wood, PhD, Alan E. Mast, MDPhD

Blood (2017) 130 (Supplement 1): 1060.

https://doi.org/10.1182/blood.V130.Suppl_1.1060.1060

Published: 2017

Journal Articles

Laboratory Assays to Address the Problem of Heparin-Protamine Balance Following Neonatal Open Heart Surgery

Julie A. Peterson, PhD, Susan A. Maroney, DVM, PhD, Wes Zwifelhofer, BS, Jeremy P. Wood, PhD, Rachel Bercovitz, MD MS, Ronald K. Woods, MD PhD, Alan E. Mast, MDPhD

Blood (2017) 130 (Supplement 1): 1111.

https://doi.org/10.1182/blood.V130.Suppl_1.1111.1111

Published: 2017

Journal Articles

Use of an Emergency Department-Based Intranasal Fentanyl Protocol for Vaso-Occlusive Episodes in Sickle Cell Disease: The Unanticipated Consequences

Kirshma Khemani, MD, Lankala Mahati Reddy, MD, Shabnam Jain, MD M.P.H, Amanda Mallino, April Zmitrovich, MSW, MPH, Bolanle Akinsola, MD, Lakshmanan Krishnamurti, MD, Claudia R. Morris, MD

Blood (2017) 130 (Supplement 1): 2264.

https://doi.org/10.1182/blood.V130.Suppl_1.2264.2264

Published: 2017

NARROW

“Mast”ering drug discovery with iPSCs

Neurodevelopmental Disorders in Pediatric Sickle Cell Disease

Proteomic Discovery: Elevated Neurogranin Levels in Children with Sickle Cell Disease

BCL-2 Is Expressed in Advanced Mastocytosis and Midaustorin Induces Venetoclax Sensitivity of Mast Leukemia Cell Lines

Red Blood Transfusion Does Not Increase Risk for Venous or Arterial Thrombosis

Parenteral L-Arginine Improves Mitochondrial Function in Children with Sickle Cell Disease Admitted for Vaso-Occlusive Pain Episodes

Blood Donation and Iron Deficiency

Inpatient Mortality and Length of Stay Among Direct-Acting Oral Anticoagulant (DOAC) and Warfarin Users Presenting with Major Hemorrhage

Critical Role of Jumonji Domain of JMJD1C in AML Leukemogenesis

Mast Cells Contribute to Brain Microvascular Permeability in Sickle Cell Disease

A New Prognostic Score for Advanced Systemic Mastocytosis Based on Clinical and Genetic Characteristics of 210 Consecutive Patients

Temporal and Spatially Regulated Oncogenic KIT Expression and Loss of Dnmt3a Cooperate to Drive MPN Development: Role of PI3Kinase in Dnmt3a Loss Induced Hyperproliferation in Myeloid Cells

AK002, a Novel Humanized Monoclonal Antibody to Siglec-8, Inhibits Mast Cell Activity and Depletes Eosinophils in Ex Vivo Bone Marrow Tissue from Patients with Systemic Mastocytosis

BFPI: A Minimal Prothrombinase Inhibitor from the Saliva of Simulium Vittatum

A Pilot Data Analysis of a Metabolomic Liquid Chromatography-Tandem Mass Spectrometry (LC/MS/MS) Based Study of Patients with Sickle Cell/Beta Thalassemia

Heme Regulates the Expression in Erythroblasts of Placenta Growth Factor, a Contributor to Pulmonary Hypertension in Sickle Cell Disease, through the Oxidant Response Transcription Factor NRF2

Free Heme Induces a Heme Importer, Heme Catabolism and an Angiogenic Factor in Multiple Organs in Mice: Implications for Organ-Specific Response to Intravascular Hemolysis

Prothrombinase Inhibition By Tfpiα Requires Three Distinct Interactions with Factors Va and X

Laboratory Assays to Address the Problem of Heparin-Protamine Balance Following Neonatal Open Heart Surgery

Use of an Emergency Department-Based Intranasal Fentanyl Protocol for Vaso-Occlusive Episodes in Sickle Cell Disease: The Unanticipated Consequences

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only